01/28/2021
https://www.msnbc.com...
"The notion that one cannot disclose danger of a product of this kind without the consent of the manufacturer is something the committee needs to look into."
"I believe we need structural reforms, like H.R. 3, if are going to bring any relief to patients about the price increases."
"AbbVie's repeated price increases of Humira have had costs to our health system with millions of dollars, and are simply unsustainable going forward."
"Thank you very much, Madam Chair. I very much appreciate your holding this hearing so that we can bring out the role of the respective parties."